Application of Lechi, a chitinase from the glycoside hydrolase family 18, in inhibiting the mycelial growth of Trichoderma shiitake.
By mining and expressing the chitinase protein of the Lechi gene, the problem of controlling Trichoderma diseases in shiitake mushrooms has been solved. It has achieved a significant inhibitory effect on Trichoderma mycelium without affecting the growth of shiitake mushrooms, providing a safe and efficient control method.
Patent Information
- Application Number
- CN202611611886.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-19
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies lack safe and efficient fungicides to control Trichoderma diseases in shiitake mushrooms, and traditional agricultural control methods are difficult to effectively control the outbreak of Trichoderma diseases, resulting in damage to production efficiency and quality.
Through interaction transcriptome analysis, the chitinase Lechi gene of the glycoside hydrolase 18 family was identified, expressed in prokaryotes, and the protein was purified. It significantly inhibited the mycelial growth of Trichoderma harzianum and Trichoderma viride, and can be used to control diseases of Trichoderma shiitake mushrooms.
Lechi protein significantly inhibits the growth of Trichoderma mycelia and reduces the colony diameter of Trichoderma harzianum and Trichoderma viride by 30.36% and 42.60%, respectively. It has no significant inhibitory effect on the growth of shiitake mushrooms and provides a safe and effective prevention and control method.
Smart Images

Figure CN123107969A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of fungal genetic engineering technology, specifically involving the application of Lechi, a chitinase of the glycoside hydrolase family 18, in inhibiting the mycelial growth of Trichoderma shiitake. Background Technology
[0002] mushroom[ Lentil plant [Berk.) Pegler] As a long-cultivated edible and medicinal fungus in my country, ranking among the top in both production and consumption, shiitake mushrooms occupy a pivotal position in the edible fungi industry. According to statistics from the China Edible Fungi Association, in 2024, my country's total shiitake mushroom production reached 13.0928 million tons, accounting for 29.82% of the country's total edible fungi production, making it the highest-producing edible fungus in my country. Its fruiting bodies not only have a unique flavor and are rich in protein, dietary fiber, vitamins, and minerals (such as potassium and selenium), but also contain various bioactive substances such as lentinan, sterols, and eritadenine. With the growth of market demand and the expansion of production scale, intensive cultivation models have been widely used, significantly improving production efficiency. However, this model relies on a single shiitake mushroom strain, pursuing high yield and early maturity, resulting in a relatively simple genetic background for the cultivated population. At the same time, the high-density cultivation environment is conducive to the spread and colonization of pathogens, making the production model more vulnerable while pursuing high efficiency.
[0003] Green mold disease, caused by fungi of the genus *Trichoderma*, is one of the most serious and difficult-to-control diseases in shiitake mushroom cultivation. This disease can occur during the mycelial growth, color-changing, and fruiting stages of shiitake mushrooms, with an incidence rate as high as 40%, severely impacting yield and quality and causing significant economic losses. To date, more than 40 species of *Trichoderma* have been identified as causing green mold disease in edible fungi. The dominant species varies depending on the cultivation period and region; common dominant species include *Trichoderma harzianum*. T. harzianum ), Trichoderma viride T. green ), dark green Trichoderma ( T. atroviride ), Pleurotus ostreatus ( T. pleuroticola ), T. macrochlamydospora and T. subvermifimicola .
[0004] Both *Trichoderma* and *Lentinula edodes* have white, filamentous mycelia, making them difficult to detect in the early stages of disease. They become visible to the naked eye only when green conidia are produced. As *Trichoderma* infects, the substrate softens and rots, failing to form fruiting bodies. Because *Trichoderma* has a strong conidial production capacity, its conidia are easily dispersed by wind, resulting in rapid spore germination and mycelial growth, making large-scale outbreaks of green mold disease likely. Since *Trichoderma* and *Lentinula edodes* belong to the same fungal family, there are currently no safe and effective fungicides specifically targeting *Trichoderma* diseases in *Lentinula edodes*. Existing fungicides can damage *Lentinula edodes*, and their rapid growth makes them prone to pesticide residues. Therefore, traditional control of fungal diseases in edible fungi relies primarily on basic agricultural methods. Furthermore, due to the highly similar growth habits of both species, simply changing cultivation conditions is insufficient to effectively control *Trichoderma* diseases. Therefore, once an outbreak occurs, it can cause severe losses; thus, finding effective control methods is crucial.
[0005] Chitin is a linear polysaccharide polymerized from N-acetylglucosamine monomers via β-1,4-glycosidic bonds. It is the second most abundant natural polysaccharide after cellulose, widely found in fungal cell walls, insect exoskeletons, and crustacean shells. Chitinases (EC 3.2.1.14) are glycoside hydrolases that catalyze the hydrolysis of chitin. Based on differences in their amino acid sequences, catalytic domains, and catalytic mechanisms, they are mainly classified into glycoside hydrolases families 18 (GH18) and 19 (GH19). GH18 family chitinases are widely distributed in bacteria, fungi, and animals, while GH19 family chitinases are mainly found in plants and some actinomycetes. All fungi contain chitinases, and all fungal-derived chitinases belong to the GH18 family, primarily involved in processes such as cell separation, spore formation, cell autolysis, immune escape, and reparasitism.
[0006] In fungal interactions, chitinases typically function as reparasites. The composition of chitinase domains directly influences their functional role in fungal interactions. In the endophytic fungus *Pyriformis inindustridium* (…),… Serendipity indicate In chitinases, the carbohydrate-binding module CBM5 confers antifungal activity, protecting plant roots from pathogen infection; conversely, the absence of CBM5 causes its function to shift towards immunosuppression, helping fungi evade host immune recognition. Furthermore, chitinases exhibit functional redundancy and synergy: *Scutellaria baicalensis* (… Coniothyrium menitans ) is Sclerotinia sclerotiorum ( Sclerotinia sclerotiorumIn *Trichoderma*, a hyperparasitic fungus, knocking out the chitinase genes CmCH1 or CmCH10 alone had no significant effect on the growth and development of *Microscutellaria baicalensis* hyphae or its parasitic ability on *Sclerotinia sclerotiorum*. However, knocking out both CmCH1 and CmCH10 simultaneously led to a decrease in the growth rate of *Microscutellaria baicalensis*, impaired protoplast release, enhanced cell wall integrity, and a significant decrease in hyperparasitic ability. Several GH18 family chitinases have been identified in *Lentinula edodes*, but related studies have mostly focused on postharvest senescence and cell wall remodeling processes. The chitinase-related functions in the *Lentinula edodes* response to *Trichoderma* are rarely reported.
[0007] This invention analyzes transcriptomic changes during the confrontation between shiitake mushrooms and Trichoderma, and identifies a candidate gene associated with resistance to Trichoderma in shiitake mushrooms. Lehi Prokaryotic expression of this gene and in vitro antibacterial assays showed that Lechi protein could significantly inhibit the growth of Trichoderma harzianum and Trichoderma viride mycelia. Summary of the Invention
[0008] The purpose of this invention is to provide a chitinase Lechi from the glycoside hydrolase 18 family and its application in inhibiting the growth of Trichoderma mycelia. By expressing Lechi protein in prokaryotes, the growth of Trichoderma harzianum and Trichoderma viride mycelia can be significantly inhibited, and there is no obvious inhibitory effect on shiitake mushroom itself.
[0009] To achieve the above objectives, the present invention adopts the following technical solution:
[0010] Transcriptome analysis of the interaction between Lentinus edodes and Trichoderma harzianum revealed the presence of chitinase genes from the glycoside hydrolase 18 family. Lehi This gene is an important candidate gene for shiitake mushrooms in response to Trichoderma harzianum stress. Lehi The CDS sequence of the gene is shown in SEQ ID NO.2, and the amino acid sequence of the Lechi protein is shown in SEQ ID NO.1.
[0011] This invention constructs Lehi The gene was expressed in a prokaryotic vector, induced and purified in vitro, and then the inhibition rate of the purified protein on the mycelial growth of *Trichoderma harzianum* and *Lentinula edodes* was determined by antibacterial assay. The results showed that, compared with the control, the protein significantly inhibited the growth of *Trichoderma harzianum* and *Trichoderma viride* mycelia, while having no significant inhibitory effect on *Lentinula edodes* mycelial growth. Specifically, compared with the blank control, the colony diameter of *Trichoderma harzianum* and *Trichoderma viride* decreased by 30.36% and 42.60%, respectively, after Lechi protein treatment. Therefore, Lechi protein can significantly inhibit the growth of *Trichoderma* mycelia and can be used for the prevention and control of *Trichoderma* diseases in *Lentinula edodes* cultivation.
[0012] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0013] Transcriptome analysis of interaction transcriptomes during the confrontation between *Lentinula edodes* and *Trichoderma harzianum* identified key candidate genes in *Lentinula edodes* responding to *Trichoderma* stress. Lehi Furthermore, by expressing Lechi protein in prokaryotes in vitro, the role of chitinase Lechi in inhibiting the mycelial growth of *Trichoderma harzianum* was discovered for the first time. Experimental results of this invention show that, compared with the control, Lechi protein treatment reduced the colony diameter of *Trichoderma harzianum* and *Trichoderma viride* by 30.36% and 42.60%, respectively, without significantly inhibiting the growth of *Trichoderma harzianum* itself. Attached Figure Description
[0014] Figure 1 : Lehi Gene structure characteristics. A represents the YS88 shiitake mushroom strain. Lehi Gene structure; B is the structural domain of the Lechi protein.
[0015] Figure 2 Induction and purification of recombinant protein Lechi. A shows the SDS-PAGE results of the Lechi-induced expression product, where M represents the protein molecular weight label, lane 1: protein before loading, lane 2: flow-through buffer, lane 3: 50 mM wash buffer, lanes 4-5: 100 mM and 250 mM imidazole elution buffers, and lanes 6-7: 500 mM imidazole elution buffer. B shows the SDS-PAGE results of the purified protein, where M represents the protein molecular weight label, and lane 1: purified protein. Note: The red arrow points to the target protein.
[0016] Figure 3 The inhibitory effect of recombinant protein Lechi on Trichoderma mycelial growth (30 h). A shows the statistical analysis of Trichoderma harzianum colony diameter under the four treatments; B shows the statistical analysis of Trichoderma viride colony diameter under the four treatments. Different lowercase letters indicate significant differences between treatments. p < 0.05).
[0017] Figure 4 Phenotypic characteristics of Trichoderma mycelia under four treatments. 0: Blank control (no liquid added); H2O: Solvent control 1 (20 µL sterile ddH2O added); TBS: Solvent control 2 (20 µL TBS buffer added); Lechi: Experimental group (20 µL recombinant protein Lechi solution added).
[0018] Figure 5The inhibitory effect of recombinant protein Lechi on the mycelial growth of *Lentinula edodes* (3 days). A shows the statistical analysis of the colony diameter of *Lentinula edodes* strain YS55 under the four treatments; B shows the statistical analysis of the colony diameter of *Lentinula edodes* strain YS88 under the four treatments; C shows the phenotype of *Lentinula edodes* mycelium under the four treatments. Note: 0: Blank control (no liquid added); H2O: Solvent control 1 (20 µL sterile ddH2O added); TBS: Solvent control 2 (20 µL TBS buffer added); Lechi: Experimental group (20 µL recombinant protein Lechi solution added). Different lowercase letters indicate significant differences between treatments. p < 0.05). Detailed Implementation
[0019] Unless otherwise specified, all methods used in the following examples are routine biological experimental methods. All primers used were synthesized by Wuhan Tianyi Huiyuan Biotechnology Co., Ltd., and sequencing was performed by Wuhan Tianyi Huiyuan Biotechnology Co., Ltd. The pEASY-Basic Seamless Cloning and Assembly Kit and pEASY-Blunt Cloning Kit were purchased from TransGen; Phanta Max Super-Fidelity DNA Polymerase was purchased from Nanjing Novizan Biotechnology Co., Ltd.; 2×T5 Super PCR Mix (Colony) was purchased from Beijing Qingke Biotechnology Co., Ltd.; restriction endonucleases were purchased from New England Biolabs; kanamycin (Kan... + The following were purchased from Qingjiang Biotechnology Co., Ltd.: San Prep column DNA recovery kit from Shanghai Huiling Biotechnology Co., Ltd.; E. coli competent cells Trans-T1 from Beijing TransGen Biotechnology Co., Ltd.; and BL21(DE3) expression bacteria from Beijing Qingke Biotechnology Co., Ltd.
[0020] Example 1: Glycoside hydrolase family 18 genes Lehi clone
[0021] The inventors analyzed the interaction transcriptomes of resistant shiitake mushroom strain YS88 and susceptible shiitake mushroom strain YS55 with *Trichoderma harzianum* at different confrontation stages, and combined this with weighted co-expression network analysis to identify important candidate genes for resistance to *Trichoderma harzianum*. Lehi . Lehi The gene belongs to the glycoside hydrolase 18 family and encodes chitinase.
[0022] The YS88 transcriptome data were assembled using Trinity V2.15.1 software, and the transcriptome data of the lentinan monokaryotic strain Wpm-1 of Lentinus edodes were extracted. Lehi The gene DNA sequence was compared with the assembled transcript to obtain YS88. Lehi Transcript sequences of the gene. Based on the sequence of the Wpm-1 reference genome and the transcriptome sequence of YS88, primers 7523-cDNA-F(8): CTCGTTGTGGCTGTGTGAAAT (SEQ ID NO.3) and 7523-cDNA-R(8): GCTTTTTACGATTAGATTACAAATTTA (SEQ ID NO.4) were designed to amplify the YS88 strain transcriptome. Lehi The DNA sequence and cDNA sequence of a gene.
[0023] PCR reaction system: 2×PhantaMax Buffer, 25 µL; primers (10 µmol / L), 2 µL each; dNTPMix, 1 µL; PhantaMax Super-Fidelity DNA Polymerase, 1 µL; template, 200 ng; add ddH2O to 50 µL.
[0024] PCR reaction parameters: 95℃ pre-denaturation for 3 min; 95℃ denaturation for 30 s, 58℃ annealing for 30 s, 72℃ extension for 2 min 40 s, cycle number 35; 72℃ extension for 10 min.
[0025] PCR amplification products were detected by 1% agarose gel electrophoresis, and gene fragments were recovered using a San Prep column-based DNA recovery kit. The fragments were ligated into pEASY-Blunt Cloning Kits. ® -BluntCloning Vector and the reaction product was transformed into E. coli Trans-T1 competent cells. The specific steps are as follows: (1) Take Trans-T1 competent cells out of -80℃ and quickly insert them into ice. After the competent cells thaw, add the ligation product and gently mix by tapping the bottom of the centrifuge tube. Let stand on ice for 5 min; (2) Heat shock in a 42℃ water bath for 45-90 s, quickly put them back into ice and let stand for 2 min; (3) Add 700 μL of sterile LB medium without antibiotics to the centrifuge tube, mix well and centrifuge at 37℃ and 200 r / min for 40-60 min; (4) Centrifuge at 6000 r / min for 1 min, take about 200 μL of supernatant, gently pipette and resuspend the bacterial block and spread it on an LB medium plate containing 50 μg / mL Kan; (5) Invert the plate and incubate overnight in a 37℃ incubator.
[0026] Single colonies were validated by PCR using universal primers M13-F: CAGGAAACAGCTATGACC (SEQ ID NO.5) and M13-R: TGTAAAACGACGGCCAGT (SEQ ID NO.6).
[0027] PCR reaction system: 2×T5 Super PCR Mix (Colony), 12.5 µL; primers (10 µmol / L), 1 µL each; template, 1 µL; add ddH2O to 25 µL.
[0028] PCR reaction parameters: 98℃ pre-denaturation for 2 min; 98℃ denaturation for 10 s, 53℃ annealing for 10 s, 72℃ extension for 40 s, cycle number 35; 72℃ extension for 2 min.
[0029] Single colonies that amplified the target band were cultured on LB medium (containing 50 μg / mL Kans). + The sample was cultured in a medium and sent to Wuhan Tianyi Huiyuan Biotechnology Co., Ltd. for sequencing to obtain YS88. Lehi DNA and cDNA sequence information.
[0030] Analysis was performed using the online alignment software Gene Structure Display Server 2.0 (https: / / gsds.gao-lab.org / ). Lehi DNA structure; amino acid sequence prediction using ExPASy (http: / / web.expasy.org); conserved domains of Lechi protein predicted using SMART (http: / / smart.embl-heidelberg.de / ).
[0031] Sequence analysis results show: Lehi The gene's full-length DNA sequence is 2593 bp, and its full-length CDS is 1614 bp, containing 8 exons and 7 introns (Figure 1A). Lehi The CDS sequence of the gene is shown in SEQ ID NO.2, and the amino acid sequence of the encoded protein is shown in SEQ ID NO.1. Using the online tool SMART, domain prediction of the encoded protein revealed that it contains a Glycohydro 18 domain, belonging to the glycoside hydrolase 18 family (Figure 1, B).
[0032] Example 2: Prokaryotic expression vector PE- Lehi Construction
[0033] use Bam HI and Hind III. The backbone of PET-28a was double-digested, and the residues were recovered by 1% agarose gel electrophoresis. Based on the nucleotide sequences at both ends of the restriction sites, recombinant primers PE-7523-F: aatgggtcgcggatccGCCCCCATCCCAAGGTTG (SEQ ID NO.7) and PE-7523-R: gtgcggccgcaagcttCGGTACAGGAAATCCTCTTCGG (SEQ ID NO.8) were designed. Using the cDNA of the resistant shiitake mushroom strain YS88 as a template, the cDNA of strain YS88 with the signal peptide and stop codon removed was amplified. Lehi CDS.
[0034] PCR amplification system: 25 µL of 2×PhantaMax Buffer, 2 µL each of primers (10 µmol / L), 1 µL of dNTPMix (10 mmol / L), 1 µL of PhantaMax Super-Fidelity DNA Polymerase (1 U / µL), 200 ng of template, and ddH2O added to a final volume of 50 µL. Reaction parameters: 95℃ pre-denaturation for 3 min; 95℃ denaturation for 30 s, 60℃ annealing for 30 s, 72℃ extension for 3 min, 35 cycles; 72℃ extension for 10 min.
[0035] Linearized backbone PET-28a, signal peptide and stop codon removed Lehi Gene fragments were ligated using a recombinase. Recombination system: linearized vector PET-28a 0.03 pmol, with signal peptide and stop codon removed. Lehi Gene CDS 0.03 pmol, 2×Basic Assembly Mix 5 µL, ddH2O added to 10 µL. After mixing, the mixture was placed in a PCR instrument and incubated at 50℃ for 15 min, then transformed into E. coli competent cells Trans-T1. Single clones were verified using primers PE-F: TTTGTTAGCAGCCGGATCTCAG (SEQ ID NO.9) and PE-R: TAGCATGACTGGTGGACAGCA (SEQ ID NO.10). Single clones with the target band were cultured in LB liquid medium (containing 50 μg / mL Kansas). + The culture was shaken and the bacterial culture was sent to Wuhan Tianyi Huiyuan Biotechnology Co., Ltd. for sequencing.
[0036] The recombinant plasmid PE-, after sequencing verification Lehi The specific steps for introducing recombinant plasmid PE- into Escherichia coli BL21(DE3) are as follows: Take 1 μL of recombinant plasmid PE- Lehi Add 100 μL of competent bacteria and incubate on ice for 20 min; heat shock at 42℃ for 45-60 s, immediately place on ice for 5 min, and add 600 μL of LB medium; incubate at 37℃ and 220 r / min for 1 h with shaking, centrifuge, and then spread entirely onto a medium containing 50 μg / mL Kansin. + LB solid plates were incubated overnight at 37°C with the plates inverted. Single clones were verified using primers PE-F and PE-R.
[0037] Example 3: Induced expression of recombinant Lechi protein
[0038] (1) Selected recombinant plasmids PE- successfully introduced Lehi A single clone of the BL21(DE3) expression strain was inoculated into 4 mL of LB liquid medium (containing 50 μg / mL Kans). + Shake overnight at 37℃ and 220 r / min.
[0039] (2) The next day, inoculate 100 mL of LB liquid medium (containing 50 μg / mL Kan) at a ratio of 1:100. + Shake at 37℃ and 220 r / min until the bacterial cell OD reaches zero. 600 It is 0.5-0.8.
[0040] (3) Add IPTG to a final concentration of 0.2 mM, shake overnight at 15℃ and 220 r / min to induce protein expression.
[0041] (4) Stop shaking the bacteria, take out 1 mL of culture, centrifuge at 10000 r / min at room temperature for 2 min, discard the supernatant, and resuspend the bacterial pellet in 100 μL TBS. After collecting the remaining culture, centrifuge at 4000 r / min for 10 min, discard the culture supernatant, and resuspend the bacterial pellet in TBS.
[0042] (5) Add PMSF to the resuspension to a final concentration of 1 mM, break it up by ultrasonication, take the supernatant, add TBS to resuspend it, perform SDS-PAGE detection and analysis, and stain with Coomassie brilliant blue for banding.
[0043] Example 4 Purification of recombinant Lechi protein
[0044] The BL21(DE3) expression strain successfully introduced with the recombinant plasmid PE-Lechi was selected for induction expression. After sonication and lysis of the bacterial cells, the supernatant was purified. The specific steps are as follows:
[0045] (1) Using a low-pressure chromatography system, the supernatant solution was loaded onto a Ni-NTA affinity chromatography column pre-equilibrated with Ni-NTA binding buffer (20 mM Tris-HCl, 0 mM imidazole, 0.5 M NaCl, pH 8.0) at a flow rate of 1 mL / min.
[0046] (2) Rinse with binding buffer at a flow rate of 1 mL / min until the effluent OD 280 The value reaches the baseline.
[0047] (3) Wash with Ni-NTA washing buffer (20 mM Tris-HCl, 50 mM imidazole, 0.5 M NaCl, pH 8.0) at a flow rate of 1 mL / min until the effluent OD 280 The value reaches the baseline.
[0048] (4) Elute the target protein with Ni-NTA elution buffer (20 mM Tris-HCl, 100 mM imidazole, 0.5 M NaCl, pH 8.0) at a flow rate of 1 mL / min and collect the effluent.
[0049] (5) Elute the target protein with Ni-NTA elution buffer (20 mM Tris-HCl, 250 mM imidazole, 0.5 M NaCl, pH 8.0) at a flow rate of 1 mL / min and collect the effluent.
[0050] (6) Elute the target protein with Ni-NTA elution buffer (20 mM Tris-HCl, 500 mM imidazole, 0.5 M NaCl, pH 8.0) at a flow rate of 1 mL / min and collect the eluent. Repeat twice.
[0051] (8) After identifying and confirming the target band, the collected protein solution is added to the dialysis bag and dialyzed overnight using TBS buffer.
[0052] (9) Perform SDS-PAGE detection and analysis, and Coomassie brilliant blue staining for banding.
[0053] (10) The concentration of the purified protein was determined using the BCA protein concentration assay kit and stored at -80℃.
[0054] The results showed that the purified product was approximately 70 kDa (Figure 2A). The theoretical molecular weight of the Lechi protein is approximately 57 kDa, but due to the presence of the vector tag sequence in the expression product, the actual molecular weight of the recombinant protein obtained was higher than the theoretical value. SDS-PAGE analysis of the purified protein yielded a relatively single band (Figure 2B), indicating high protein purity. Further LC-MS mass spectrometry analysis of the purified protein sample, as shown in Table 1, revealed that the protein belongs to the glycosidase 18 family, with 22 specific peptides matched, and a theoretical molecular weight of 58.109 kDa, consistent with expectations.
[0055] Table 1. Results of protein spectroscopy analysis after purification
[0056] Example 5: Antibacterial test of recombinant Lechi protein against shiitake mushrooms and Trichoderma.
[0057] To investigate the effect of chitinase on the growth of *Trichoderma*, the following treatments were set up in the center of PDA culture dishes: ① Blank control (no liquid added); ② Solvent control 1 (20 µL of sterile ddH2O added); ③ Solvent control 2 (20 µL of LTBS buffer added); ④ Experimental group (20 µL of 0.29 mg / mL recombinant Lechi protein solution added). Subsequently, 8 mm diameter *L. shiitake* mycelial cakes (YS55 or YS88) or 6 mm diameter *Trichoderma* mycelial cakes (*Trichoderma harzianum* or *Trichoderma viride*, hyphal side down) were inoculated into the center of the culture dish and incubated at 25℃. Mycelial growth was observed and colony diameter was measured.
[0058] The results showed that treatment with recombinant Lechi protein for 30 h significantly inhibited the growth of both *Trichoderma harzianum* and *Trichoderma viride*. Compared with the blank control, the colony diameters of the two *Trichoderma* species decreased by 30.36% and 42.60%, respectively (Figure 3). The phenotype of *Trichoderma* hyphae was as follows: Figure 4 As shown in Figure 5, after 3 days of the same treatment, the protein did not show a significant inhibitory effect on the growth of either of the two shiitake mushroom species. This indicates that the Lechi recombinant protein has a certain inhibitory effect on Trichoderma harzianum and Trichoderma viride, but has no significant effect on the growth of shiitake mushrooms themselves.
Claims
1. A chitinase Lechi protein belonging to the glycoside hydrolase family, characterized in that, The amino acid sequence of the protein Lechi is shown in SEQ ID NO.
1.
2. The coding sequence of the Lechi protein according to claim 1, characterized in that, The encoded sequence is shown in SEQ ID NO.
2.
3. A recombinant vector containing the coding sequence of the Lechi protein as described in claim 2.
4. A host cell containing the recombinant vector of claim 3.
5. The application of the Lechi protein according to claim 1 in the prevention and control of Trichoderma harzianum and Trichoderma viride diseases in shiitake mushrooms.
6. A method for preventing infection with Trichoderma harzianum and Trichoderma viride in shiitake mushrooms, characterized in that, The Lechi protein of claim 1 is applied during the cultivation of shiitake mushrooms.
